Selective activation of TCR-γδ+ cells in endemic Burkitt's lymphoma

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Futagbi, Godfred ^a,b   Welbeck, Jennifer E ^c   Tetteh, John Kweku A ^a   Hviid, Lars ^d,e   Akanmori, Bartholomew D ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PHYCOERYTHRIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; BLOOD SAMPLING; BURKITT LYMPHOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMODIUM FALCIPARUM; SCHOOL CHILD; T LYMPHOCYTE; CHILD; FEMALE; GHANA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALARIA FALCIPARUM; MALE; METABOLISM; PATHOPHYSIOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; GHANA; HUMANS; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 34250869078     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-69     Document Type: Article

References (22)

1. Etiology of Burkitt's lymphoma - an alternative hypothesis to a vectored virus. DP Burkitt, J Natl Cancer Inst 1969 42 19 28 4303830
2. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. G de-Thé A Geser NE Day PM Tukei EH Williams DP Beri PG Smith AG Dean GW Bornkamm P Feorino W Henle, Nature 1978 274 756 761 10.1038/274756a0 210392
3. Burkitt's lymphoma. Clues to the role of malaria. MA Epstein, Nature 1984 312 398 10.1038/312398a0 6095098
4. Long-term T-cell-mediated immunity to Epstein- Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. DJ Moss AB Rickinson JH Pope, Int J Cancer 1978 22 662 668 10.1002/ijc.2910220604 214405
5. Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumour. GT O'Conor, Am J Med 1970 48 279 285 10.1016/0002-9343(70)90057-4 4190958
6. The γ/δ T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. L Hviid JAL Kurtzhals D Dodoo O Rodrigues A Ronn JOO Commey FK Nkrumah TG Theander, Infect Immun 1996 64 4359 4362 8926112
7. High frequency of circulating γδ Tcells with dominance of the Vd1 subset in a healthy population. L Hviid BD Akanmori S Loizon JAL Kurtzhals CH Ricke A Lim KA Koram FK Nkrumah O Mercereau-Puijalon C Behr, Int Immunol 2000 12 797 805 10.1093/intimm/12.6.797 10837407
8. + gd T-cells in African children with Plasmodium falciparum malaria. L Hviid JAL Kurtzhals V Adabayeri S Loizon K Kemp BQ Goka A Lim O Mercereau-Puijalon BD Akanmori C Behr, Infect Immun 2001 69 3190 3196 11292740 10.1128/IAI.69.5.3190- 3196.2001
9. A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells. L Hviid G Albeck B Hansen TG Theander A Talbot, J Immunol Methods 1993 157 135 142 10.1016/0022-1759(93)90079-M 8423356
10. Statistics with confidence. British Medical Journal, BMJ, London London, UK: BMJ Publishing Group, Altman D, Machin D, Bryant T, Gardner M, 2000
11. Lymphocyte changes in acute malaria. BM Greenwood AJ Oduloju D Stratton, Trans R Soc Trop Med Hyg 1977 71 408 410 10.1016/0035-9203(77)90039-6 304268
12. Transient depletion of T-cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. L Hviid TG Theander NH Abdulhadi YA Abu-Zeid RAL Bayoumi JB Jensen, Eur J Immunol 1991 21 1249 1253 10.1002/eji.1830210523 1674690
13. Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. L Hviid TG Theander YA Abu-Zeid NH Abdulhadi PH Jakobsen BO Saeed S Jepsen RAL Bayoumi JB Jensen, FEMS Microbiol Immunol 1991 76 219 228 10.1111/j.1574-6968.1991.tb04218.x
14. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. DK Wagner J Kiwanuka BK Edwards LA Rubin DL Nelson, J Clin Oncol 1987 5 1262 1274 3114436
15. Serum levels and differential expression of intercellular adhesion molecule-1 in childhood leukemia and malignant lymphoma: prognostic importance and relationship with survival. N Tacyildiz G Yavuz S Gozdasoglu E Unal U Ertem F Duru A Ikinciogullari E Babacan A Ensari A Okcuoglu-Cavdar, Pediatr Hematol Oncol 1999 16 149 158 10.1080/088800199277470 10100275
16. Evidence of endothelial inflammation, T-cell activation, and T-cell reallocation in uncomplicated Plasmodium falciparum malaria. IM Elhassan L Hviid G Satti B Akerström PH Jakobsen JB Jensen TG Theander, Am J Trop Med Hyg 1994 51 372 379 7524374
17. Polyclonal B-cell activation during rodent malarial infections. RR Freeman CR Parish, Clin Exp Immunol 1978 32 41 45 352584
18. Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia. DM Banic FS Viana-Martins JM De Souza TD Peixoto C Daniel-Ribeiro, Am J Trop Med Hyg 1991 44 571 577 2063961
19. T- cell control of Epstein-Barr virus-infected B-cells is lost during P. falciparum malaria. HC Whittle J Brown K Marsh BM Greenwood P Seidelin H Tighe L Wedderburn, Nature 1984 312 449 450 10.1038/312449a0 6095104
20. + subset of human gd T-cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. G Hacker S Kromer M Falk K Heeg H Wagner K Pfeffer, J Immunol 1992 149 3984 3989 1334108
21. + gd T-cells. DL Orsini M van Gils YM Kooy L Struyk G Klein P van-den Elsen F Koning, Eur J Immunol 1994 24 3199 3204 10.1002/eji.1830241243 7528674
22. + T lymphocytes during progression of HIV infection. EM Hyjek J Bartkowiak R Drozdz TJ Wasik M Jasinski Y Kaneko HW Lischner D Kozbor, J Immunol 1997 158 464 4 8977224